Research & Development
Evofem signs exclusive deal to expand SOLOSEC distribution in sub-Saharan Africa
27 April 2026 - Women's health company Evofem Biosciences Inc (OTCID: EVFM) disclosed on Monday that it has entered into an exclusive distribution agreement with pharmaceutical distributor Clovis...
GSK secures US and EU fast-track designations for efimosfermin in MASH
27 April 2026 - Biopharmaceutical company GSK plc (LSE: GSK) (NYSE: GSK) announced on Monday that it has received Breakthrough Therapy Designation from the US Food and Drug Administration, as well as ...
AstraZeneca secures US approval for Saphnelo self-administration in lupus treatment
27 April 2026 - Biopharmaceutical company AstraZeneca PLC (LSE: AZN) (STO: AZN) (NYSE: AZN) declared on Monday that it has received US Food and Drug Administration approval for the subcutaneous self-a...
Abbott presents late-breaking clinical data on treating heart rhythm disorders
27 April 2026 - Global healthcare company Abbott (NYSE:ABT) on Saturday announced new late-breaking data from four trials that demonstrate strong clinical outcomes within its pulsed field ablation (PF...
Novartis receives positive CHMP opinion for Itvisma in spinal muscular atrophy
24 April 2026 - Swiss pharmaceutical company Novartis AG (SIX:NOVN) (NYSE:NVS) announced on Friday that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA)...
Servier completes Day One Biopharmaceuticals acquisition
24 April 2026 - French pharmaceutical company Servier announced on Thursday the successful completion of its tender offer to acquire all of the issued and outstanding shares of common stock of Day One...